Is there a role for lung surgery in initially unresectable non-small cell lung cancer after tyrosine kinase inhibitor treatment?

BACKGROUND: The role of lung surgery in initially unresectable non-small cell lung cancer (NSCLC) after tyrosine kinase inhibitor (TKI) treatment remains unclear. We aimed to assess the survival benefits of patients who underwent surgery for regressed or regrown tumors after receiving TKI treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Diong, Nguk Chai, Liu, Chia-Chuan, Shih, Chih-Shiun, Wu, Mau-Ching, Huang, Chun-Jen, Hung, Chen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701021/
https://www.ncbi.nlm.nih.gov/pubmed/36434641
http://dx.doi.org/10.1186/s12957-022-02833-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701021/
https://www.ncbi.nlm.nih.gov/pubmed/36434641
http://dx.doi.org/10.1186/s12957-022-02833-6

Ejemplares similares